Q. I had breast cancer in the past, and I’m really scared of it coming back. What can you tell me about recurrent breast cancer?
A. Recur (“re-occur”) means the same breast cancer you initially experienced has returned. It may come back in your breast (the same one, if you had a lumpectomy; or the other breast); but it may also come back in another part of your body. The important thing to remember is recurrent breast cancer is the SAME cancer you had initially.
It’s possible for you to...
Read moreQ. I have "triple negative" breast cancer - it's not estrogen-, progesterone-, or HER2-positive, so my treatment has so far been limited to... Read more »
Q. I've just found out I have to have chemotherapy. The doctor said it's AC and Taxol [or Taxotere]. What does that mean, exactly? A.... Read more »
A breast cancer treatment study published in the New England Journal of Medicine this week has the national media hopping–and me... Read more »
Avastin, a drug given conditional FDA approval for the treatment of metastatic breast cancer last February, is now one step closer to... Read more »
After enduring four grueling rounds of Taxol during my chemotherapy treatments, imagine my disappointment upon learning that it may have... Read more »
A large study of tibolone, a drug used to treat menopausal symptoms and to prevent osteoporosis, was halted early after researchers found that the... Read more »
Many survivors of breast cancer report having decreased sexual desire and drive. There are often several possible causes of diminished sex drive in... Read more »
Ten natural compounds found in pomegranates appears to reduce the risk of estrogen-fueled breast cancer, U.S. researchers say. The chemicals block... Read more »
The commissioner of the U.S. Food and Drug Administration has revoked the approval of Avastin as a breast cancer drug. In June, an FDA advisory... Read more »
U.S. Food and Drug Administration (FDA) officials have recommended revoking approval of the medication Avastin (bevacizumab) for the treatment of... Read more »